Aldose Reductase Inhibitor, Epalrestat, Reduces Lipid Hydroperoxides in Type 2 Diabetes-Reference-Cited by-同舟云学术

Aldose Reductase Inhibitor, Epalrestat, Reduces Lipid Hydroperoxides in Type 2 Diabetes

Published:2009 Issue:1 Volume:56 Page:149-156
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

OHMURA Chie¹,WATADA Hirotaka¹,AZUMA Kosuke¹,SHIMIZU Tomoaki¹,KANAZAWA Akio¹,IKEDA Fuki¹,YOSHIHARA Tomoaki¹,FUJITANI Yoshio¹²,HIROSE Takahisa¹²,TANAKA Yasushi¹,KAWAMORI Ryuzo¹²³

Affiliation:

1. Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine

2. Center for Therapeutic Innovations in Diabetes, Juntendo University School of Medicine

3. Center for Beta Cell Biology and Regeneration, Juntendo University School of Medicine

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/56/1/56_K08E-237/_pdf

Reference38 articles.

1. Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose

2. 2. Peppa M, Vlassara H (2005) Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens) 4: 28-37.

3. Diabetes and advanced glycation endproducts

4. 4. Ishii H, Koya D, King GL (1998) Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76: 21-31.

5. Activation of the Hexosamine Pathway Leads to Deterioration of Pancreatic β-Cell Function through the Induction of Oxidative Stress

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation design and evaluation of epalrestat mouth dissolving tablets comprising superdisintegrant from natural sources manufactured by direct compression method and stability studies of optimized formulation;PAK J PHARM SCI;2023

2. Elucidation and Application of Novel Action of Therapeutic Agents for Diabetic Neuropathy;YAKUGAKU ZASSHI;2022-10-01

3. Advanced Glycation End Products and Oxidative Stress in a Hyperglycaemic Environment;Fundamentals of Glycosylation;2022-01-26

4. Renal Tubular Handling of Glucose and Fructose in Health and Disease;Comprehensive Physiology;2021-12-29

5. Enhanced Oral Bioavailability of Epalrestat SBE7-β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation;International Journal of Nanomedicine;2021-12